TORONTO, ONTARIO--(CCNMatthews - March 31, 2006) - (All amounts in thousands of Canadian dollars, except per share data). Orbus Pharma Inc. (TSX:ORB) reported that the net loss for the year ended December 31, 2005 was $6,813 ($0.22 per share) compared to net loss of $5,266 ($0.17 per share) in 2004. The net loss for the fourth quarter was $1,722 ($0.05 per share) compared to net loss of $2,239 ($0.07 per share) in 2004.
